Table 2.
Selected demographic and clinical characteristics analyzed in a multivariable model on overall survival in individuals diagnosed with sarcoma at MCC, 1986–2014.
| Overall Survival aHR (95% CI) a |
|
|---|---|
| Age at Diagnosis (yrs) | |
| 15–39 | 1.00 (referent) |
| ≥40 | 1.54 **** (1.34–1.78) |
| Ethnicity | |
| Non-Hispanic | 1.00 (referent) |
| Hispanic | 1.01 (0.83–1.23) |
| Unknown | 2.00 * (1.07–3.74) |
| Tobacco Use | |
| Never | 1.00 (referent) |
| Former User | 1.07 (0.93–1.22) |
| Current User | 1.18 * (1.01–1.37) |
| Unknown | 1.00 (0.79–1.26) |
| Sarcoma Type | |
| Bone sarcoma | 1.00 (referent) |
| STS | 1.07 (0.92–1.23) |
| Spread | |
| Localized | 1.00 (referent) |
| Metastatic | 2.19 **** (1.95–2.47) |
| Undefined | 1.10 (0.49–2.46) |
| Unknown | 1.12 (0.58–2.16) |
| First Course of Treatment Included Chemotherapy | |
| Yes | 1.00 (referent) |
| No | 0.77 **** (0.69–0.87) |
| First Course of Treatment Included Surgery | |
| Yes | 1.00 (referent) |
| No | 2.11 **** (1.82–2.45) |
| First Course of Treatment Included Radiation | |
| Yes | 1.00 (referent) |
| No | 0.97 (0.86–1.09) |
Abbreviations: STS = soft tissue sarcoma; aHR = adjusted hazard ratio; CI = confidence interval. a All characteristics were included in a single multivariable model to calculate aHR. * p ≤ 0.05, **** p ≤ 0.0001.